Antiphospholipid antibodies in relation to sterility/infertility

Human Immunology

Volumn 73, Issue 7, 2012, Pages 726-731

  Kovács, Mónika ^a   Hartwig, Marianna ^a   Aleksza, Magdolna ^b   Tihanyi, Marianna ^a   Nagy, Tatjána ^a   Vajda, Gyorgy ^a   Daru, József ^c   Gasztonyi, Beáta ^a  

^a Zala County Hospital   (Hungary)

^b UNIVERSITY OF WEST HUNGARY   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBODY; ANTIBODY AGAINST EXTRACTABLE NUCLEAR ANTIGEN; ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; LEVOTHYROXINE; LIPOCORTIN 5 ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHATIDYL SERINE ANTIBODY; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; SPERM ANTIBODY; THYROID PEROXIDASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; DRUG DOSE REDUCTION; FEMALE; FEMALE INFERTILITY; FEMALE STERILITY; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PHYSICAL EXAMINATION; PREGNANCY; PRIORITY JOURNAL; SECONDARY ANTIPHOSPHOLIPID SYNDROME; SEROLOGY; SPONTANEOUS ABORTION;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFERTILITY, FEMALE; PREDNISONE; PREGNANCY; PREGNANCY OUTCOME; SEROLOGY;

EID: 84862337911     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.04.003     Document Type: Article

References (22)

1. Rowe P.J., Comhaire F.H., Hargreave T.B., Mellows H.J. WHO manual for the standard investigation and diagnosis of the infertile couple 1993, Cambridge University Press, Cambridge.
2. Lampé L., Papp Z. Sterility and infertility. Obstetrics and Gynecology 1992, 65-67. Semmelweis Publishing House, Budapest. 5th ed. L. Lampé, Z. Papp (Eds.).
3. Gergely P. Antiphospholipid syndrome. Clinical Immunology 2006, 156-161. Medicina Publishing House, Budapest. 1st ed. L. Czirják (Ed.).
4. Lockshin M.D. Pregnancy loss and antiphospholipid antibodies. Lupus 1998, 7(Suppl. 2):86-89.
5. Szodoray P., Bacskó G.y., Lakos G., Zeher M. Combined treatment of a pregnant woman with antiphospholipid syndrome. Orv Hetil 2003, 144:2411-2413.
6. Zeher M. Systemic autoimmune diseases and gravidity. Magy Reumatol 2005, 46:79-85.
7. Cervera R., Balasch J. Bidirectional effects on autoimmunity and reproduction. Hum Reprod Update 2008, 14:359-366.
8. Gómez-Puerta J.A., Cervera R., Espinosa G., Asherson R.A., Carcia-Carrasco M., P da Costa I., et al. For the Catastrophic Antiphospholipid Syndrome Registry Project Group/European Forum on Antiphospholipid Antibodies. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal caracteristics of 15 cases. Ann Rheum Dis 2007, 66(6):740-746.
9. Buckingham K.L., Chamley L.W. A critical assessment of the role antiphospholipid antibodies in infertility. J Reprod Immunol 2009, 80:132-145.
10. Pattison N.S., Chamley L.W., Birdsall M., Zanderigo A.M., Liddell H.S., McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlles trial. Am J Obstet Gynecol 2000, 4:1008-1012.
11. Pajor A. Gravidity and obstetric immunology. Clinical Immunology 2006, 398-403. Medicina Publishing House, Budapest. 1st ed. L. Czirják (Ed.).
12. Zammiti W., Mtiraoui N., Kallel Ch., Mercier E., Almawi W.Y., Mahjoub T. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against β2-glycoprotein I and annexin V. Human Reprod 2006, 131:817-822.
13. Zammiti W., Mtiraoui N., Hidar S., Fekih M., Almawi W.Y., Mahjoub T. Antibodies to β2-glycoprotein I and annexin V in women with aerly and late idiopathic recurrent spontaneous abortions. Arch Gynecol Obstet 2006, 274:261-265.
14. Piette J.C., Wechsler B., Frances C., Papo T., Godeau P. Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 1993, 10:1802-1804.
15. Marai I., Carp H., Shai S., Shabo R., Fishman G., Shoenfeld Y. Autoantibody panel screening in recurrent miscarriages. Am J Reprod Immunol 2004, 51:235-240.
16. Rubinstein M., Marazzi A., Polak de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 1999, 5:825-829.
17. Farquharson R.G., Quenby S., Greaves M. Antiphospholipid Syndrome in Pregnancy: A Randomized. Controlled Trial of Treatment. Obstet Gynecol 2002, 100:408-413.
18. Rai R., Cohen H., Dave M., Regan I. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with ercurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997, 314:253-257.
19. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584-1589.
20. Hasegawa I., Yamanoto Y., Suzuki M., Murakawa H., Kurabayashi T., Takakuwa K., et al. Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertil Steril 1998, 6:1044-1048.
21. Sullivan A., Branch D.W. How to treat the antiphospholipid syndrome in pregnancy?. No{doubleacute}gyógyászati és Szülészeti Továbbképzo{doubleacute} Szemle 2002, 3:159-167.
22. Triolo G., Ferrante A., Ciccia F., Accardo-Palumbo A., Perino A., Castelli A., et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arth Rheum 2003, 3:728-731.